Lutetium (177 lu) vipivotide tetraxetan

Pluvicto

Soluzione iniettabile o per infusioneItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

PluvictoCanada · 1000 MBq / ML · Solution · Novartis Pharmaceuticals Canada INCSame brand
PluvictoEuropean Union · Novartis Europharm LimitedSame brand
PluvictoCroatiaSame brand
Pluvicto 1.000 MBq/ml oplossing voor injectie/infusieNetherlands · Oplossing voor injectie of infusie · Novartis Europharm LimitedSame brand
PLUVICTO SOLUTION FOR INJECTION/INFUSION 1000 MBq/mLSingapore · 1000 MBq/mL · injection, solution (radiopharmaceutical) · Novartis (Singapore) Pte LTDSame brand

Packs

Pack	Code	Status
1 000 MBq / mL - Soluzione iniettabile o per infusione - Uso endovenoso - Flaconcino (vetro) 7,5 ? 12,5 mL - 1 flaconcino	050419011	Autorizzata

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lutetium (177 lu) vipivotide tetraxetan

Pluvicto

Soluzione iniettabile o per infusioneItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
1 000 MBq / mL - Soluzione iniettabile o per infusione - Uso endovenoso - Flaconcino (vetro) 7,5 ? 12,5 mL - 1 flaconcino	050419011	Autorizzata

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lutetium (177 lu) vipivotide tetraxetan
Dosage form: Soluzione iniettabile o per infusione
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 050419
Marketing authorisation holder: Novartis Europharm Limited
ATC code: V10XX05
Group: Various
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile